FdaApplication
ANDA 220269
Identifiers
- fda_app_no: ANDA220269
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMAZONE |
| application_type | ANDA |
| approval_date | 2026-04-07 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE | 75MG;25MG | CAPSULE;ORAL |
1 product